Colgan Erin has filed 10 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 3627 shares of Sensei Biotherapeutics, Inc. ($SNSE) on February 15, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | CHIEF FINANCIAL OFFICER | F | Common Stock | 3627 | $0.79 | 67,462.0000 | 27,952,857 | 5.10% | 0.01% |
| Feb. 15, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 27,952,857 | 9999.99% | 0.45% |
| Feb. 15, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | CHIEF FINANCIAL OFFICER | A | Stock Option (Right to Buy) | 94128 | $0.00 | 94,128.0000 | 27,952,857 | 9999.99% | 0.34% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | Chief Financial Officer | F | Common Stock | 10943 | $1.50 | 68,089.0000 | 0 | 13.85% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | Chief Financial Officer | A | Common Stock | 30046 | $0.00 | 57,732.0000 | 0 | 108.52% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | Chief Financial Officer | A | Common Stock | 21300 | $0.00 | 79,032.0000 | 0 | 36.89% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | Chief Financial Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | Chief Financial Officer | A | Common Stock | 30046 | $0.00 | 51,732.0000 | 0 | 138.55% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | Chief Financial Officer | A | Common Stock | 21300 | $0.00 | 73,032.0000 | 0 | 41.17% | 0.00% |
| Feb. 15, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Colgan Erin | Chief Financial Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |